Golden Jubilee National Hospital
Glasgow G814DY
1 studies enrolling now · 19 studies all time
What they study most
Acute Anterior Myocardial Infarction, Acute Coronary Syndrome, Acute Myocardial Infarction, Cardiovascular Diseases, Cardiovascular Risk Factors, Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Coronary Artery Disease, Coronary Disease, Coronary Stenosis, Heart Failure, High Bleeding Risk, PAH
Studies at this site
- The Oxford Risk Factors And Non-Invasive Imaging Study — Recruiting now
- A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease — Completed
- A Study of Acute Myocardial Infarction Using FDY-5301 — Completed
- Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
- Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST — Stopped early
- REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension — Completed
- A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging — Stopped early
- A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) — Stopped early
- Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry — Completed
- MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing — Stopped early
- Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension — Completed
- A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) — Completed
- LEADERS FREE II: BioFreedom™ Pivotal Study — Running, not enrolling
- CXA-10 Study in Subjects With Pulmonary Arterial Hypertension — Stopped early
- PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) — Stopped early
- FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT — Completed
- Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation — Completed
- MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction — Stopped early
- The INFUSE - Anterior Myocardial Infarction (AMI) Study — Completed